Man Injected Himself With 'Magic Mushrooms' And Fungi Grew In His Blood
A man injected himself with 'magic mushrooms', which caused fungi to grow in his blood and his organs to fail.
The 30-year-old man, from Nebraska, US, was rushed to the hospital after his family noticed that he was acting a little strange and seemed to be in a state of confusion.
According to the case study in the Journal of the Academy of Consultation-Liaison Psychiatry, the man had bipolar disorder type one, and doctors discovered he hadn't been taking his medications and had been going through a series of manic and depressive episodes.
HIs family said that during one of his episodes he tried to research ways of reducing his opioid intake, and read about how psilocybin, the drug found in magic mushrooms, could be used to help with anxiety and depression.
And while a study carried out by researchers at Johns Hopkins found that the drug helped cancer patients who were suffering from bouts of depression, it is not meant to be injected.
According to the case study, the man boiled his mushrooms in water and filtered the liquid through a cotton swab before injecting it.
A couple of days later, he began feeling extremely tired and started vomiting blood, suffering from diarrhea, and developed jaundice.
After finding him, his family rushed him to hospital.
More Like ThisMore Like This
Following a series of tests, the report says, doctors found that the mushrooms had started to grow in his bloodstream, which had damaged his liver and kidneys, and caused his organs to start failing.
The patient also needed to be put on a ventilator to help him breathe and to have his blood filtered for toxins.
He was kept in hospital for 22 days and was prescribed two antibiotics and one antifungal treatment to keep taking after being discharged.
Last month, it was revealed that the the first official steps had been made to get to reschedule some illegal drugs so that they can be investigated for any medicinal benefits.
Mind Medicine Australia submitted the first applications to Australia's Therapeutic Goods Administration (TGA) in order to research psilocybin and MDMA.
Mind Medicine Australia wrote on its website: "The rescheduling would move these medicines from Schedule 9 of the Uniform Scheduling of Medicines and Poisons (which deals with Prohibited Substances) to Schedule 8 (which deals with Controlled Medicines).
"The changes proposed by Mind Medicine Australia will not affect existing legal controls on illicit use or supply.
"The rescheduling will enable psychiatrists and specialist addiction physicians to more easily access these medicines to augment therapy for patients suffering from key mental illnesses such as depression, PTSD and for the depression and anxiety often associated with a terminal illness diagnosis (and hopefully in the future for substance abuse, OCD, anorexia and early stage dementia).
"It will also relieve a significant part of the regulatory burden associated with undertaking trials with these medicines in Australia."
Featured Image Credit: Pikist
Chosen for YouChosen for You
Most Read StoriesMost Read